Yasuo Ihara

Title: Yasuo Ihara: Innovator in Neurobiology

Introduction

Yasuo Ihara is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of neurobiology, particularly in understanding growth inhibitory factors related to neural development and diseases.

Latest Patents

Ihara holds 2 patents that focus on groundbreaking research in neurobiology. His latest patents include a non-naturally-occurring polypeptide that exhibits neural growth inhibitory action. This polypeptide has an amino acid sequence that is crucial for its function. Additionally, he has developed a novel protein known as Growth Inhibitory Factor (GIF), which is present in the brains of normal subjects but absent in patients with Alzheimer’s disease. This protein was cloned from a human-cerebral cDNA library and human genomic DNA library. Furthermore, Escherichia coli was transformed with a vector integrated by the cDNA to express GIF. The DNA coding for the cloned GIF can be utilized in genetic diagnosis and gene therapy for Alzheimer’s disease, allowing for large-scale production of GIF.

Career Highlights

Yasuo Ihara is currently associated with Takeda Chemical Industries, Inc., where he continues to advance his research in neurobiology. His work has been instrumental in exploring the mechanisms of neural growth and the implications for neurodegenerative diseases.

Collaborations

Ihara has collaborated with notable colleagues, including Yoko Uchida and Shoji Tsuji, to further his research and innovations in the field.

Conclusion

Yasuo Ihara's contributions to neurobiology through his patents and research are paving the way for advancements in understanding and treating Alzheimer’s disease. His work exemplifies the impact of innovative research on healthcare and the potential for future discoveries.